Clinical trial

Role of Adrenaline in in the Inflammatory Response in Diabetes

NCT05990933

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-12-03

PhaseNA

Study timeline

Study start (actual)2023-12-03Date precision: day

Registry last updated2024-11-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Inflammatory Responseunresolved

Diabetes Type1unresolved

Hypoglycemiaunresolved

Interventions

AdrenalineDRUG

Sponsors & collaborators

Cees Tacklead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05990933 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.